Dianne Angus has executive managerial and company director experience in the biotechnology, biopharmaceutical, agritech and healthcare industries; including practical experience in innovation curation, asset development and commercialisation.
She also has over 18 years of experience in ASX- and NASDAQ-listed companies including Neuren Pharmaceuticals and Prana Biotechnology (now Alterity Therapeutics).